Abstract
A review of the management of COPD is presented, with particular emphasis on the effect on the approach to management of new information which has become available in the 5 years since the BTS guidelines on COPD were published. A major problem is the effective implementation of what is already known, and allocation of the resources necessary to make this available to all who might benefit.
MeSH terms
-
Administration, Inhalation
-
Adrenal Cortex Hormones / administration & dosage
-
Anti-Bacterial Agents / therapeutic use
-
Antioxidants / therapeutic use
-
Bronchodilator Agents / therapeutic use
-
Expectorants / therapeutic use
-
Humans
-
Oxygen / therapeutic use
-
Practice Guidelines as Topic
-
Pulmonary Disease, Chronic Obstructive / diagnosis
-
Pulmonary Disease, Chronic Obstructive / surgery
-
Pulmonary Disease, Chronic Obstructive / therapy*
-
Smoking Cessation
-
Vaccines / therapeutic use
Substances
-
Adrenal Cortex Hormones
-
Anti-Bacterial Agents
-
Antioxidants
-
Bronchodilator Agents
-
Expectorants
-
Vaccines
-
Oxygen